Imunon, Inc. Assets, Noncurrent
Imunon, Inc. (IMNN) had Assets, Noncurrent of $17.07 million as of 2020-09-30, per its 10-Q filed 2020-11-16.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AssetsNoncurrent · last filed 2020-11-16
- 2020-09-30: Assets, Noncurrent $17.07M.
- 2020-06-30: Assets, Noncurrent $19.59M.
- 2020-03-31: Assets, Noncurrent $19.69M.
- 2019-12-31: Assets, Noncurrent $21.64M.
| Period end | Assets, Noncurrent | Assets, Noncurrent as first filed |
|---|---|---|
| 2020-09-30 | $17.07M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $19.59M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $19.69M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $21.64M 10-Q · filed 2020-11-16 | |
| 2019-09-30 | $20.02M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $20.15M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $20.24M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $18.54M 10-K · filed 2020-03-25 | |
| 2018-09-30 | $18.49M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $22.98M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $22.97M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $23.03M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $23.08M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $25.66M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $25.82M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $25.87M 10-K · filed 2018-03-27 | |
| 2016-09-30 | $27.89M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $27.89M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $27.89M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $27.89M 10-K · filed 2017-03-24 | $27.92M 10-K · filed 2016-03-30 |
| 2015-09-30 | $27.93M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $27.94M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $28.01M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $28.02M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $28.03M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $28.18M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $1.14M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $1.08M 10-K · filed 2015-03-12 | |
| 2013-09-30 | $386.67K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $420.11K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $503.54K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $595.31K 10-K · filed 2014-03-13 | |
| 2012-09-30 | $635.37K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $551.92K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $356.38K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $358.25K 10-Q · filed 2012-11-09 | |
| 2011-09-30 | $387.39K 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $202.09K 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $119.92K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |